850 related articles for article (PubMed ID: 1904554)
1. New use of BCG for recombinant vaccines.
Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
[TBL] [Abstract][Full Text] [Related]
2. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
Fuerst TR; Stover CK; de la Cruz VF
Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
Aldovini A; Young RA
Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity elicited by rBCG vaccines.
Stover CK; Bansal GP; Langerman S; Hanson MS
Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
[TBL] [Abstract][Full Text] [Related]
5. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
[TBL] [Abstract][Full Text] [Related]
6. Recombinant BCG as an antigen delivery system.
Flynn JL
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
8. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
Dietrich G; Viret JF; Hess J
Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
[TBL] [Abstract][Full Text] [Related]
10. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
11. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
DasGupta SK; Jain S; Kaushal D; Tyagi AK
Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
[TBL] [Abstract][Full Text] [Related]
12. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
Dennehy M; Bourn W; Steele D; Williamson AL
Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
[TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
Dai W; Huangfu Y; Zheng B
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
[TBL] [Abstract][Full Text] [Related]
15. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys.
Yasutomi Y; Koenig S; Haun SS; Stover CK; Jackson RK; Conard P; Conley AJ; Emini EA; Fuerst TR; Letvin NL
J Immunol; 1993 Apr; 150(7):3101-7. PubMed ID: 8454878
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of live recombinant BCG vaccines.
Hanson MS; Bansal GP; Langermann S; Stover CK; Orme I
Dev Biol Stand; 1995; 84():229-36. PubMed ID: 7796958
[TBL] [Abstract][Full Text] [Related]
18. Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
Oliveira TL; Rizzi C; Dellagostin OA
Appl Microbiol Biotechnol; 2017 Sep; 101(18):6865-6877. PubMed ID: 28779291
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
[TBL] [Abstract][Full Text] [Related]
20. Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens.
Rezende CA; De Moraes MT; De Souza Matos DC; McIntoch D; Armoa GR
J Virol Methods; 2005 Apr; 125(1):1-9. PubMed ID: 15737410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
